Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

309

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

July 31, 2006

Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL

adalimumab

40 mg eow, sc

Trial Locations (25)

Unknown

Tokyo

Aichi

Chiba

Ehime

Fukui

Fukuoka

Gunma

Hokkaido

Hyōgo

Ibaraki

Ishikawa

Kagoshima

Kanagawa

Kyoto

Miyagi

Nagano

Nagasaki

Niigata

Okayama

Osaka

Saitama

Shizuoka

Tochigi

Tokushima

Toyama

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Abbott Japan Co.,Ltd

INDUSTRY

collaborator

Eisai Co., Ltd.

INDUSTRY

lead

Abbott

INDUSTRY